Axxess Pharma Expands Sales with Large Purchase Orders within the United States and Canada
Purchase Orders are for the Full Line of Oatein Protein Cookies, Protein Bars and Protein Flapjacks
(firmenpresse) - TORONTO, ON -- (Marketwired) -- 11/29/16 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce they have received large purchase orders for the full line of Oatein protein cookies, protein bars and protein Flapjacks. The purchase orders were from the United States and Canada. Management is now in discussions with major retailers in order to expand sales of the popular nutritional line. Based on the current demand, the company anticipates a continued acceleration of orders from both countries over the next 6 months.
Oatein protein cookies, protein bars and protein Flapjacks are unique, compared to most of the products on the market. The nutritional products come from an oat based recipe, which gives it a home baked freshness that tastes like confectionary but is guilt free. The full line of products is high in protein, strong in fiber and slowly provides an energy release for today''s health conscious individuals. These guilt free, healthy products include four flavors of Oatein Super Cookies. These flavors are milk chocolate, double chocolate chip, white chocolate and blueberry, and salted caramel.
Michael Gelmon, President of Axxess Pharma, stated, "We are very excited to receive large purchase orders for our full line of protein bars, Flapjacks and protein cookies. This unique line of nutritional products is designed to meet the needs of millions of health conscious individuals that are on the go. These individuals range from corporate employees, construction workers, truck drivers, fitness enthusiasts and more." Mr. Gelmon further stated, "This special line of nutritional products is perfectly priced and packaged for retail chain stores, convenience stores and fitness facilities. We anticipate this line of nutritional products will generate strong residual revenues for our company throughout 2017 and 2018."
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements, over the counter remedies, sportswear all across the Americas. Axxess''s goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure and acute pain, to optimal health management through improved nutritional supplements.
For more information, please visit , or contact Investor Relations at .
Statements about the Company''s future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
Axxess Pharma Inc.
Daniel Bagi, MD.
E-mail:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.11.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 1472556
Anzahl Zeichen: 1957
contact information:
Contact person:
Town:
TORONTO, ON
Phone:
Kategorie:
Food
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 275 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Axxess Pharma Expands Sales with Large Purchase Orders within the United States and Canada
"
steht unter der journalistisch-redaktionellen Verantwortung von
Axxess Pharma Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
